Kamyar Kalantar-Zadeh M.D. to Atherosclerosis
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Atherosclerosis.
Connection Strength
1.333
-
Role of HDL dysfunction in end-stage renal disease: a double-edged sword. J Ren Nutr. 2013 May; 23(3):203-6.
Score: 0.405
-
High platelet count as a link between renal cachexia and cardiovascular mortality in end-stage renal disease patients. Am J Clin Nutr. 2011 Sep; 94(3):945-54.
Score: 0.359
-
Serum Low-Density Lipoprotein Cholesterol and Cardiovascular Disease Risk Across Chronic Kidney Disease Stages (Data from 1.9 Million United States Veterans). Am J Cardiol. 2022 05 01; 170:47-55.
Score: 0.187
-
Risk of Atherosclerotic Cardiovascular Disease and Nonatherosclerotic Cardiovascular Disease Hospitalizations for Triglycerides Across Chronic Kidney Disease Stages Among 2.9?Million US Veterans. J Am Heart Assoc. 2021 12 07; 10(23):e022988.
Score: 0.182
-
High-density lipoprotein in uremic patients: metabolism, impairment, and therapy. Int Urol Nephrol. 2014 Jan; 46(1):27-39.
Score: 0.100
-
Protein carbamylation predicts mortality in ESRD. J Am Soc Nephrol. 2013 Apr; 24(5):853-61.
Score: 0.100